Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen–Specific CD8 T Cell Responses during Theiler's Virus Infection
Published version of a preprint
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Theiler's murine encephalomyelitis virus (TMEV) infection of the CNS is cleared in C57BL/6 mice by a CD8 T cell response restricted by the MHC class I molecule H-2Db. The identity and function of the APC(s) involved in the priming of this T cell response is (are) poorly defined. To address this gap in knowledge, we developed an H-2Db LoxP-transgenic mouse system using otherwise MHC class I–deficient C57BL/6 mice, thereby conditionally ablating MHC class I–restricted Ag presentation in targeted APC subpopulations. We observed that CD11c+ APCs are critical for early priming of CD8 T cells against the immunodominant TMEV peptide VP2121-130. Loss of H-2Db on CD11c+ APCs mitigates the CD8 T cell response, preventing early viral clearance and immunopathology associated with CD8 T cell activity in the CNS. In contrast, animals with H-2Db–deficient LysM+ APCs retained early priming of Db:VP2121-130 epitope–specific CD8 T cells, although a modest reduction in immune cell entry into the CNS was observed. This work establishes a model enabling the critical dissection of H-2Db–restricted Ag presentation to CD8 T cells, revealing cell-specific and temporal features involved in the generation of CD8 T cell responses. Employing this novel system, we establish CD11c+ cells as pivotal to the establishment of acute antiviral CD8 T cell responses against the TMEV immunodominant epitope VP2121-130, with functional implications both for T cell–mediated viral control and immunopathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMEV infection is cleared from the brain approximately between 14 – 21 days post infection8, 19.”
In the citing paper
“Db expressing mice resolve TMEV infection in 14–21 days8, 19.”
In the citing paper
“While it is known that CD11c+ APCs are critical for early priming of CD8 T cells against the immunodominant TMEV peptide VP2121–130, it was not fully understood whether other NVU cell types could provide a secondary stimulatory event that expands the antigen specific CD8 T cell response in the brain parenchyma19.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
Jordão, M. J. C., Sankowski, R., Brendecke, S. M., Sagar, Locatelli, G., Tai, Y.-H., Tay, T. L., Schramm, E., Armbruster, S., Hagemeyer, N., et al. (2019) · Science · doi:10.1126/science.aat7554 · Cited by 843
What is immune privilege (not)?
Galea, I., Bechmann, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.004 · Cited by 768
Mundt, S., Mrdjen, D., Utz, S. G., Greter, M., Schreiner, B., & Becher, B. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau8380 · Cited by 235
Olson, J. K., Girvin, A. M., & Miller, S. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9780-9789.2001 · Cited by 178 · cited 1×
“OVA Ag to naive CD8 T cells in vivo, and other works have confirmed that TMEV infection is sufficient to drive microglia toward an activated, APC-like, phenotype (74, 75).”
BackgroundWlodarczyk, A., Løbner, M., Cédile, O., & Owens, T. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-57 · Cited by 149
In vivo dynamics of innate immune sentinels in the CNS
Nayak, D., Zinselmeyer, B. H., Corps, K. N., & McGavern, D. B. (2012) · IntraVital · doi:10.4161/intv.22823 · Cited by 109
Suidan, G. L., Dickerson, J. W., Johnson, H. L., Chan, T. W., Pavelko, K. D., Pirko, I., Seroogy, K. B., & Johnson, A. J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-218 · Cited by 19
Self-citation
Research works printed but not linked: 69
- Mockus, 2019, To go or stay: the development, benefit, and detriment of tissue-resident memory CD8 T cells during central nervous system viral infections, 842
- Aguilar-Valenzuela, 2018, Dynamics of tissue-specific CD8+ T cell responses during west nile virus infection, J. Virol., 92, 10.1128/JVI.00014-18 · DOI
- Wang, 2003, CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis, J. Virol., 77, 13323, 10.1128/JVI.77.24.13323-13334.2003 · DOI · Paper page
- Guermonprez, 2002, Antigen presentation and T cell stimulation by dendritic cells, Annu. Rev. Immunol., 20, 621, 10.1146/annurev.immunol.20.100301.064828 · DOI · Paper page
- Bulloch, 2008, CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain, J. Comp. Neurol., 508, 687, 10.1002/cne.21668 · DOI · Paper page
- McMenamin, 1999, Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations, J. Comp. Neurol., 405, 553, 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6 · DOI · Paper page
- Prodinger, 2011, CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system, Acta Neuropathol., 121, 445, 10.1007/s00401-010-0774-y · DOI
- Clarkson, 2014, Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE, J. Neuroimmunol., 277, 39, 10.1016/j.jneuroim.2014.09.016 · DOI
- Clarkson, 2015, CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression, J. Immunol., 194, 531, 10.4049/jimmunol.1401320 · DOI
- De Laere, 2018, To the brain and back: migratory paths of dendritic cells in multiple sclerosis, J. Neuropathol. Exp. Neurol., 77, 178, 10.1093/jnen/nlx114 · DOI
- Bernhard, 2015, CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells, Proc. Natl. Acad. Sci. USA, 112, 5461, 10.1073/pnas.1423356112 · DOI · Paper page
- Kivisäkk, 2009, Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis, Ann. Neurol., 65, 457, 10.1002/ana.21379 · DOI · Paper page
- Pope, 1998, Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler’s murine encephalomyelitis virus, J. Virol., 72, 7762, 10.1128/JVI.72.10.7762-7771.1998 · DOI
- van Zwam, 2011, Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo, J. Leukoc. Biol., 90, 123, 10.1189/jlb.1209813 · DOI
- Libbey, 2014, Axonal pathology and demyelination in viral models of multiple sclerosis, Discov. Med., 18, 79
- DePaula-Silva, 2017, Theiler’s murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: models for multiple sclerosis and epilepsy, J. Neuroimmunol., 308, 30, 10.1016/j.jneuroim.2017.02.012 · DOI · Paper page
- Drescher, 2008, Being a mouse in a man’s world: what TMEV has taught us about human disease, Front. Biosci., 13, 3775, 10.2741/2966 · DOI
- Tsunoda, 2010, Neuropathogenesis of Theiler’s murine encephalomyelitis virus infection, an animal model for multiple sclerosis, J. Neuroimmune Pharmacol., 5, 355, 10.1007/s11481-009-9179-x · DOI · Paper page
- Azoulay, 1994, FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler’s virus, J. Virol., 68, 4049, 10.1128/jvi.68.6.4049-4052.1994 · DOI
- Rodriguez, 1985, Demyelination induced by Theiler’s virus: influence of the H-2 haplotype, J. Immunol., 135, 2145, 10.4049/jimmunol.135.3.2145 · DOI · Paper page
- Rodriguez, 1995, H-2 Dd transgene suppresses Theiler’s virus-induced demyelination in susceptible strains of mice, J. Neurovirol., 1, 111, 10.3109/13550289509111015 · DOI
- Bell, 2014, An elite controller of picornavirus infection targets an epitope that is resistant to immune escape, PLoS One, 9, 10.1371/journal.pone.0094332 · DOI
- Borson, 1997, Brain-infiltrating cytolytic T lymphocytes specific for Theiler’s virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue, J. Virol., 71, 5244, 10.1128/jvi.71.7.5244-5250.1997 · DOI · Paper page
- Dethlefs, 1997, Theiler’s virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice, J. Virol., 71, 5361, 10.1128/jvi.71.7.5361-5365.1997 · DOI
- Johnson, 1999, Prevalent class I-restricted T-cell response to the Theiler’s virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28, J. Virol., 73, 3702, 10.1128/JVI.73.5.3702-3708.1999 · DOI · Paper page
- Johnson, 2001, Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler’s virus infection, FASEB J., 15, 2760, 10.1096/fj.01-0373fje · DOI
- Willenbring, 2016, Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption, J. Neuroinflammation, 13, 222, 10.1186/s12974-016-0673-9 · DOI · Paper page
- Mendez-Fernandez, 2003, Clearance of Theiler’s virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide, Eur. J. Immunol., 33, 2501, 10.1002/eji.200324007 · DOI · Paper page
- Johnson, 2005, Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome, J. Immunol., 174, 6854, 10.4049/jimmunol.174.11.6854 · DOI · Paper page
- Johnson, 2012, CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support, J. Immunol., 189, 1937, 10.4049/jimmunol.1200658 · DOI
- Johnson, 2012, A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption, J. Neuroinflammation, 9, 60, 10.1186/1742-2094-9-60 · DOI
- Johnson, 2014, Theiler’s murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption, J. Neurovirol., 20, 107, 10.1007/s13365-013-0187-5 · DOI
- Johnson, 2014, Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption, PLoS One, 9, 10.1371/journal.pone.0111401 · DOI · Paper page
- Malo, 2018, Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 + T cell responses, Nat. Commun., 9, 633, 10.1038/s41467-018-03037-x · DOI
- Cumba Garcia, 2016, Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique, J. Immunol. Methods, 439, 23, 10.1016/j.jim.2016.09.002 · DOI
- Rodriguez, 1986, Partial suppression of Theiler’s virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens), Neurology, 36, 964, 10.1212/WNL.36.7.964 · DOI · Paper page
- Abram, 2014, Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice, J. Immunol. Methods, 408, 89, 10.1016/j.jim.2014.05.009 · DOI · Paper page
- Noubade, 2019, Beyond cDC1: emerging roles of DC crosstalk in cancer immunity, Front. Immunol., 10, 1014, 10.3389/fimmu.2019.01014 · DOI
- McCaughtry, 2008, Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla, J. Exp. Med., 205, 2575, 10.1084/jem.20080866 · DOI · Paper page
- Klein, 2014, Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see), Nat. Rev. Immunol., 14, 377, 10.1038/nri3667 · DOI · Paper page
- Oh, 2015, The role of dendritic cells in central tolerance, Immune Netw., 15, 111, 10.4110/in.2015.15.3.111 · DOI
- Tsunoda, 2008, Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection, Future Virol., 3, 579, 10.2217/17460794.3.6.579 · DOI
- Lipton, 1975, Theiler’s virus infection in mice: an unusual biphasic disease process leading to demyelination, Infect. Immun., 11, 1147, 10.1128/iai.11.5.1147-1155.1975 · DOI · Paper page
- Palma, 2001, Enhanced susceptibility to Theiler’s virus-induced demyelinating disease in perforin-deficient mice, J. Neuroimmunol., 116, 125, 10.1016/S0165-5728(01)00293-4 · DOI
- Fiette, 1993, Theiler’s virus infection of beta 2-microglobulin-deficient mice, J. Virol., 67, 589, 10.1128/jvi.67.1.589-592.1993 · DOI
- Rodriguez, 1993, Abrogation of resistance to Theiler’s virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin, J. Immunol., 151, 266, 10.4049/jimmunol.151.1.266 · DOI
- Rodriguez, 1991, Role of T cells in resistance to Theiler’s virus infection, Microb. Pathog., 11, 269, 10.1016/0882-4010(91)90031-5 · DOI
- Suidan, 2008, Induction of blood brain barrier tight junction protein alterations by CD8 T cells, PLoS One, 3, 10.1371/journal.pone.0003037 · DOI · Paper page
- Ling, 2008, In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices, J. Immunol., 180, 8393, 10.4049/jimmunol.180.12.8393 · DOI
- Mendez-Fernandez, 2005, Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler’s virus infection, J. Virol., 79, 3063, 10.1128/JVI.79.5.3063-3070.2005 · DOI
- Probst, 2005, Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells, Clin. Exp. Immunol., 141, 398, 10.1111/j.1365-2249.2005.02868.x · DOI · Paper page
- Steel, 2009, Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system, Virology, 387, 117, 10.1016/j.virol.2009.01.032 · DOI · Paper page
- Altintas, 1993, Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler’s virus, J. Immunol., 151, 2803, 10.4049/jimmunol.151.5.2803 · doi:10.4049/jimmunol.151.5.2803
- Lin, 1997, Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection, Eur. J. Immunol., 27, 963, 10.1002/eji.1830270424 · DOI
- Njenga, 1997, Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system, Lab. Invest., 77, 71
- Pavelko, 2012, Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity, PLoS Pathog., 8, 10.1371/journal.ppat.1002541 · DOI
- MacNamara, 2008, Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent, J. Virol., 82, 6150, 10.1128/JVI.00106-08 · DOI
- Herz, 2011, In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity, J. Neuroinflammation, 8, 131, 10.1186/1742-2094-8-131 · DOI
- Hughes, 2016, Antigen-presenting cells and antigen presentation in tertiary lymphoid organs, Front. Immunol., 7, 481, 10.3389/fimmu.2016.00481 · DOI
- Mitsdoerffer, 2016, Tertiary lymphoid organs in central nervous system autoimmunity, Front. Immunol., 7, 451, 10.3389/fimmu.2016.00451 · DOI · Paper page
- Cose, 2006, Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway, Eur. J. Immunol., 36, 1423, 10.1002/eji.200535539 · DOI · Paper page
- Allan, 2006, Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming, Immunity, 25, 153, 10.1016/j.immuni.2006.04.017 · DOI · Paper page
- Brabb, 2000, In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity, J. Exp. Med., 192, 871, 10.1084/jem.192.6.871 · DOI · Paper page
- Reynoso, 2019, Lymph node conduits transport virions for rapid T cell activation, Nat. Immunol., 20, 602, 10.1038/s41590-019-0342-0 · DOI · Paper page
- Milo, 2013, Dynamic imaging reveals promiscuous crosspresentation of blood-borne antigens to naive CD8+ T cells in the bone marrow, Blood, 122, 193, 10.1182/blood-2012-01-401265 · DOI
- Pozzi, 2005, Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells, J. Immunol., 175, 2071, 10.4049/jimmunol.175.4.2071 · DOI · Paper page
- Jarry, 2013, Efficiently stimulated adult microglia cross-prime naive CD8+ T cells injected in the brain, Eur. J. Immunol., 43, 1173, 10.1002/eji.201243040 · DOI
- Coder, 2017, Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging, Oncotarget, 8, 7116, 10.18632/oncotarget.12572 · DOI · Paper page
- McGavern, 2002, T cells in the central nervous system: the delicate balance between viral clearance and disease, J. Infect. Dis., 186, S145, 10.1086/344264 · DOI · Paper page
Cited by
Johnson, A., Seady, M., Maynes, M., Thelwell, J., Jin, F., Hansen, M., Jensen, H., Witter, R., Owens, C., Hassani, A., et al. (2026) · doi:10.21203/rs.3.rs-10061124/v1
Self-citation
Metadata
- Authors
- Tritz, Z. P., Orozco, R. C., Malo, C. S., Ayasoufi, K., Fain, C. E., Khadka, R. H., Goddery, E. N., Yokanovich, L. T., Settell, M. L., Hansen, M. J., Jin, F., Pavelko, K. D., Pease, L. R., & Johnson, A. J.
- Affiliations
- Mayo Clinic Graduate School of Biomedical Sciences , Rochester, MN 55905
- Mayo Clinic Department of Immunology , Rochester, MN 55905
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-09-01
- Volume
- 205
- Issue
- 5
- Pages
- 1228-1238
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 18
- References
- 9
- Language
- en
- Funders
- National Institute of Neurological Disorders and Stroke (NS103212)
- National Institutes of Health (T32 AI07425-24)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.